Acting director of the Federal Center for Biologics Evaluation and Research.

Dr. Karen Midthun, acting director of the Federal Center for Biologics Evaluation and Research, said that Provenge offered: – A new treatment option for men with advanced prostate cancer. Two-week intervals currently limited effective treatments have provided .

So far, the fusion PAX3/FOXO1 was used only as classification agent for histology, but never as a prognostic indicator. The research team found that children who called called rhabdomyosarcoma with this genetic defect have a significantly worse survival rates than other rhabdomyosarcoma patients. Could be used is thus very useful in predicting patient survival.To receive a diagnosis of metabolic syndrome, patients should three of the following five risk factors: abdominal adiposity , low HDL , other metabolic , high blood pressure and high blood glucose. – ‘Doctors are often reluctant to to prescribe testosterone of Service not related the sexual function,’said trial co-author, Farid Saad, residents of Berlin , Bayer Schering Pharma. ‘But our study shows to testosterone has a much broader therapeutic role than just to improve sexual desire and erectile function domain score. ‘.. Has of testosterone deficiency , which is more often to age not to decreased to a decreased sex drive, but also to a number of medical problems. They include have the metabolic syndrome , a cluster of metabolic risk factors increase the chances of developing heart disease, stroke and type 2 diabetes.